Par Pharmaceutical, Inc.
Par Pharmaceutical, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 1978, the company has established itself as a leader in the development and manufacturing of generic and specialty pharmaceuticals. With a strong focus on high-quality, affordable medications, Par Pharmaceutical serves a diverse range of therapeutic areas, including oncology, pain management, and anti-infectives. The company is recognised for its commitment to innovation, particularly in the production of complex generics and niche products that meet specific patient needs. Par Pharmaceutical has achieved significant milestones, including strategic partnerships and a robust pipeline of products that enhance its market position. With a dedication to excellence and patient care, Par Pharmaceutical continues to make a meaningful impact in the healthcare landscape.
DitchCarbon Score
How does Par Pharmaceutical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Par Pharmaceutical, Inc.'s score of 23 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Par Pharmaceutical, Inc.'s reported carbon emissions
Par Pharmaceutical, Inc., headquartered in the US, currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions data to analyse. Additionally, the company has not outlined any formal reduction targets or commitments to climate initiatives, such as Science-Based Targets Initiative (SBTi) goals or other climate pledges. In the absence of specific emissions data and reduction initiatives, it is unclear how Par Pharmaceutical is addressing its carbon footprint or contributing to broader climate action efforts within the pharmaceutical industry.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Par Pharmaceutical, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
